Abstract | PURPOSE: We investigated the usefulness of [(99m)Tc] duramycin for monitoring early response to cancer therapy in mice, with an eye towards clinical translation. PROCEDURES: [(99m)Tc] Duramycin was injected in healthy CD1-/- mice to estimate human [(99m)Tc] duramycin radiation dose. [(99m)Tc] Duramycin single-photon emission computed tomography (SPECT) imaging of apoptosis was evaluated in a mouse model of colorectal cancer treated with irinotecan and validated ex vivo using autoradiography, cleaved caspase-3, and TdT-mediated dUTP nick-end labeling (TUNEL) histology of the tumors. RESULTS: The mean effective dose was estimated to be 3.74 × 10(-3) ± 3.43 × 10(-4) mSv/MBq for non-purified and 3.19 × 10(-3) ± 2.16 × 10(-4) mSv/MBq for purified [(99m)Tc] duramycin. [(99m)Tc] Duramycin uptake in vivo following therapy increased significantly in apoptotic irinotecan-treated tumors (p = 0.008). Radioactivity in the tumors positively correlated with cleaved caspase-3 (r = 0.85, p < 0.001) and TUNEL (r = 0.92, p < 0.001) staining. CONCLUSION:
|
Authors | Filipe Elvas, Christel Vangestel, Sara Rapic, Jeroen Verhaeghe, Brian Gray, Koon Pak, Sigrid Stroobants, Steven Staelens, Leonie Wyffels |
Journal | Molecular imaging and biology
(Mol Imaging Biol)
Vol. 17
Issue 6
Pg. 838-47
(Dec 2015)
ISSN: 1860-2002 [Electronic] United States |
PMID | 25896815
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Validation Study)
|
Chemical References |
- Bacteriocins
- Peptides
- duramycin
- Technetium
|
Topics |
- Animals
- Apoptosis
- Bacteriocins
(administration & dosage, chemistry, pharmacokinetics)
- Female
- Mice
- Mice, Nude
- Neoplasms, Experimental
(diagnostic imaging, metabolism, pathology)
- Peptides
(administration & dosage, chemistry, pharmacokinetics)
- Technetium
(administration & dosage, chemistry, pharmacokinetics)
- Tissue Distribution
- Tomography, Emission-Computed, Single-Photon
(methods)
|